Fingerprint
Dive into the research topics of 'Emerging nondopaminergic medications for parkinson’s disease: Focusing on a2a receptor antagonists and glp1 receptor agonists'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Emerging nondopaminergic medications for parkinson’s disease: Focusing on a2a receptor antagonists and glp1 receptor agonists
Pei Shang, Matthew Baker, Samantha Banks, Sa Ik Hong, Doo Sup Choi
Research output: Contribution to journal › Review article › peer-review